Trexquant Investment LP Aquestive Therapeutics, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$3.29 - $5.21 $33,646 - $53,282	-10,227 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$4.17 - $6.73 $42,646 - $68,827	10,227 New	10,227 $53,000
Q1 2020 May 08, 2020	SELL	$1.54 - $6.75 $34,409 - $150,822	-22,344 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$3.06 - $8.78 $68,372 - $196,180	22,344 New	22,344 $130,000
Q2 2019 Aug 09, 2019	SELL	$3.72 - $6.95 $48,032 - $89,738	-12,912 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$5.74 - $8.05 $74,114 - $103,941	12,912 New	12,912 $89,000

126

47.1M

517K

207K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $161M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.